PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Jan-2022 Amerigo Scientific Launches Polycaprolactone for Bioprinting Amerigo Scientific
25-Jan-2022 CD ProGPCR Launches Gene Expression Profiling Services for GPCRs Research CD ProGPCR
25-Jan-2022 Amerigo Scientific Announces Collagen Bio Tubes for Life Science Researchers Amerigo Scientific
25-Jan-2022 CD Bioparticles Introduces New D-Glucosamines for Research Use CD Bioparticles
25-Jan-2022 CD Bioparticles Announces New Protein Magnetic Particles for Bio-application CD Bioparticles
25-Jan-2022 Creative Diagnostics Announces the Offering of Native Viral Antigens Creative Diagnostics
25-Jan-2022 Amerigo Scientific Announces Tissue Plasminogen Activator for Bio-research Amerigo Scientific
25-Jan-2022 Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis Creative Proteomics
24-Jan-2022 CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service CD Genomics
22-Jan-2022 Creative Enzymes Introduces Instant Granules to Shorten the Experimental Process Creative Enzymes
21-Jan-2022 First Platform for Massively Multiplexed Single-Cell In Situ Spatial Genomics Now Broadly Available to U.S. Market Vizgen
21-Jan-2022 CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development CD Formulation
21-Jan-2022 CD Formulation: Customized Preparation of Active Pharmaceutical Ingredient Excipients to Accelerate Drug Formulation Projects CD Formulation
21-Jan-2022 Quantum Dots & Upconverting Nanoparticles Provided by Alfa Chemistry Can Improve Medical Technology and Energy Research Alfa Chemistry
20-Jan-2022 River BioMedics Raises Seed Investment to Progress its Cardiovascular Disease Programs River BioMedics
19-Jan-2022 JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS PATIENTS IN GREAT BRITAIN Galapagos NV
18-Jan-2022 Eisbach Bio and MD Anderson announce strategic collaboration to develop medicines targeting epigenetic machinery in oncology Eisbach Bio
18-Jan-2022 Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022 Avance Clinical
17-Jan-2022 Seekyo reinforces scientific advisory board with two new members Andrew Lloyd Associates
13-Jan-2022 Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance Porda